AN2 Therapeutics, Inc.

NasdaqGS:ANTX Stock Report

Market Cap: US$40.0m

AN2 Therapeutics Dividends and Buybacks

Dividend criteria checks 0/6

AN2 Therapeutics does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-0.1%

Buyback Yield

Total Shareholder Yield-0.1%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

We're Keeping An Eye On AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Rate

Nov 21
We're Keeping An Eye On AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Rate

Is AN2 Therapeutics (NASDAQ:ANTX) In A Good Position To Invest In Growth?

Jul 04
Is AN2 Therapeutics (NASDAQ:ANTX) In A Good Position To Invest In Growth?

Here's Why We're Not Too Worried About AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Situation

Mar 23
Here's Why We're Not Too Worried About AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Situation

AN2 Therapeutics (NASDAQ:ANTX) Is In A Good Position To Deliver On Growth Plans

Dec 05
AN2 Therapeutics (NASDAQ:ANTX) Is In A Good Position To Deliver On Growth Plans

AN2 Therapeutics (NASDAQ:ANTX) Is In A Good Position To Deliver On Growth Plans

Aug 20
AN2 Therapeutics (NASDAQ:ANTX) Is In A Good Position To Deliver On Growth Plans

We Think AN2 Therapeutics (NASDAQ:ANTX) Can Afford To Drive Business Growth

May 09
We Think AN2 Therapeutics (NASDAQ:ANTX) Can Afford To Drive Business Growth

We're Not Very Worried About AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Rate

Feb 03
We're Not Very Worried About AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Rate

We're Hopeful That AN2 Therapeutics (NASDAQ:ANTX) Will Use Its Cash Wisely

Oct 21
We're Hopeful That AN2 Therapeutics (NASDAQ:ANTX) Will Use Its Cash Wisely

AN2 Therapeutics secures $17.8M contract from NIH

Sep 29

We Think AN2 Therapeutics (NASDAQ:ANTX) Can Afford To Drive Business Growth

Jul 01
We Think AN2 Therapeutics (NASDAQ:ANTX) Can Afford To Drive Business Growth

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if ANTX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ANTX's dividend payments have been increasing.


Dividend Yield vs Market

AN2 Therapeutics Dividend Yield vs Market
How does ANTX dividend yield compare to the market?
SegmentDividend Yield
Company (ANTX)n/a
Market Bottom 25% (US)1.4%
Market Top 25% (US)4.2%
Industry Average (Pharmaceuticals)2.4%
Analyst forecast (ANTX) (up to 3 years)n/a

Notable Dividend: Unable to evaluate ANTX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ANTX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate ANTX's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ANTX has not reported any payouts.


Discover strong dividend paying companies